“The readiness is all.” It’s hard to think of an emerging product category where retailers and suppliers have taken Hamlet’s admonition more seriously than CBD. As attitudes about cannabis, hemp and products derived from them have shifted, and the legal and regulatory restrictions around them have started to unravel, many chains and an extensive roster
Editor’s note: This is Part I of an article that ran in the 1/21/19 issue of CDR. As legal cannabis-based products continue to find their way to market, promising to redefine entire categories from health, beauty and wellness to food and beverage in their wake, most chain drug retailers are scrambling to calculate the impact
CHICAGO — A.T. Kearney has acquired Cervello, an elite business analytics and data management consultancy. Operating as Cervello, an A.T. Kearney company, its team of data engineers, data scientists, and developers will work closely with Kearney client service teams worldwide to power client performance improvement and transformation programs with technology consulting, analytics, and data-driven insights.
CHIGACO — Holiday shoppers are more than prepared to buy in force this year. The only question is who will capture their dollars. Three out of four consumers (76%) plan to spend as much or more than they did last year, but, according to A.T. Kearney’s 2018 Holiday Shopping Survey: How Retailers Can Capitalize on
Editor’s note: The second in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. There is no question that science is rapidly accelerating the health care opportunities we see in the marketplace. Broader genetics capabilities could mean new services and treatments based on genetic makeup that
CHICAGO — Recent research by A.T. Kearney into American and Canadian consumer attitudes toward legalized cannabis revealed that more than three-quarters (76%) would try medicinal cannabis products and about half would try cannabis-enhanced consumer products such as snack foods (55%), nutritional supplements (50%) and cosmetics (43%). While North American attitudes toward marijuana are relaxing almost as
The high value of pharmaceutical shipments has traditionally meant that all parties in the chain drug industry were primarily concerned with quality. They needed a reliable, transparent solution. Given that shipping represented a tiny percentage of drug costs, price was a lesser concern. But recently shipping rates have increased sharply. Is there anything the industry
While 2018 looks to be on pace to continue the recent fervid spate of traditional mergers and acquisitions — measured in terms of number of deals, size of deals, or both — it may be best remembered as the year that a bold new approach to M&As that we call “neumarkets” revolutionized retailing and a
We are now more than 20 years into the e-commerce era of retail. As many brick-and-mortar retail sectors have found creative ways to combat the online threat, pharmacy chains too are identifying the most effective solutions. One area that offers an opportunity for improvement is payments. For digitally savvy customers, the checkout experience — the
A perfect storm is brewing for drug retailers’ supply chain managers, third-party logistics suppliers (3PLs) and the carriers they work with. After U.S. logistics costs declined 1.5% in 2016, the first half of 2017 was flat due to lingering overcapacity and rate pressures that had shippers asking for — and still getting — rate reductions.
Millennials have been a hot topic of conversation for more than a decade. It’s the one generational group that continues to confound both employers and retailers: How do we attract them, engage them and retain them? Yet a majority of employees and shoppers are them. Identified as those born between 1981 and 1997, Millennials became
The impact of a healthy population and vibrant workforce on the ability of the economy to sustain growth should not be underestimated. While Congress has been mired in a political debate around the near-term costs and burden of the Affordable Care Act, lost from this deeply partisan discussion is a tangible, forward-thinking consideration of the
The American economist Edgar Fiedler appropriately warned that “he who lives by the crystal ball soon learns to eat ground glass.” Fiedler aside, chain drug retailers may want to consider a series of future commercial opportunities emerging from what — at least at times — might appear to be the disruptive chaos of today’s market.
On July 4, 2026, when America marks its 250th birthday, will the nation be stable and prosperous? That is the core question behind America@250 — a multiyear initiative launched by A.T. Kearney, in partnership with The Wall Street Journal. Muhtar Kent of Coca-Cola Co., Chip Bergh of Levi Strauss, Rhonda Vetere of Estée Lauder Cos.,